MASI logo

Masimo (MASI)

Profile

Full Name

Masimo Corporation

Ticker Symbol

MASI

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 8, 2007

Indexes

Not included

Website

http://www.masimo.com

Employees

3600

Key Details

Price

$153.61(-0.19%)

Market cap

$8.29B(Mid cap)

Last Dividend

$1.00

TTM Dividend yield

-

Annual revenue

$2.09B(+2.26% YoY)

Annual EPS

-$5.72(-478.81% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$153.61
MASI price is $153.61

30-Day Relative Volume

1.08
MASI 30-day relative volume is 1.08

Price Performance

Price Most recent change

-0.19%
MASI price was down -0.19% on Apr 14, 2025

Price YTD change

-7.07%
MASI price is down -7.07% since January 1st

Price 1-year change

+11.22%
MASI price is up +11.22% year-on-year

Price 3-year change

+13.89%
MASI price is up +13.89% over the past 3 years

Price Range

Price All-time high

$305.21
MASI price is currently -49.67% below its historical high of $305.21

Price 3-year low

$75.22
MASI price is currently +104.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.29B
MASI market capitalization is $8.29 billion

Market cap 3-year change

+10.7%
MASI market capitalization is up +10.7% over the past 3 years

Market cap All-time high

$16.75B
MASI market capitalization is currently -50.52% below its historical high of $16.75 billion

Market cap sector rank

91.78%
MASI market capitalization is higher than 91.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.63%
MASI shares outstanding is up +1.63% year-on-year

Shares Outstanding 3-Year Change

-2.8%
MASI shares outstanding is down -2.8% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.15
MASI beta is 1.15

200-day SMA

$148.78
MASI price is currently +3.25% above its 200-day simple moving average

50-day SMA

$170.81
MASI price is currently -10.07% below its 50-day simple moving average

RSI

43.98
MASI 14-day relative strength index is 43.98

Volume

1.08
MASI 30-day relative volume is 1.08

ATR

$9.93
MASI average true range is $9.93

10-day Historical Volatility

109.69%
MASI 10-day historical volatility is 109.69%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.00
MASI last dividend was $1.00 per share, with an ex-dividend date of November 23, 2012

Next Dividend

-
MASI next dividend has not yet been announced

Dividend per share

Dividend per share

-
MASI annual dividend per share value is unknown

Dividend per share Sector Rank

-
MASI annual dividend per share is unknown

Dividend per share 1-Year Change

-
MASI annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
MASI annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
MASI annual dividend yield value is unknown

Dividend yield Sector Rank

-
MASI annual dividend yield is unknown

Other

Payout ratio

-
MASI annual payout ratio value is unknown

Dividends paid

-
MASI annual dividends paid value is unknown

Free cash flow

$145.30M
MASI annual free cash flow is $145.30 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.09B
MASI annual revenue is $2.09 billion

Revenue Analysts estimate

$1.52B
MASI annual revenue is currently +38.06% higher than the consensus analysts' forecast

Revenue 1-year change

+2.26%
MASI annual revenue is up +2.26% year-on-year

Revenue Sector rank

85.33%
MASI annual revenue is higher than 85.33% of companies in Healthcare sector

EPS

EPS

-$5.72
MASI annual earnings per share is -$5.72

EPS Analysts estimate

$5.25
MASI annual earnings per share is currently -209.03% lower than the consensus analysts' forecast

EPS 1-year change

-478.81%
MASI annual earnings per share is down -478.81% year-on-year

EPS Sector rank

17.37%
MASI annual earnings per share is higher than 17.37% of companies in Healthcare sector

Profit

Gross profit

$1.00B
MASI annual gross profit is $1.00 billion

Gross margin

47.96%
MASI annual gross profit margin is 47.96%

Operating profit

$37.80M
MASI annual operating income is $37.80 million

Operating margin

1.80%
MASI annual operating profit margin is 1.80%

Net income

-$304.90M
MASI annual net profit is -$304.90 million

Net margin

-14.56%
MASI annual net profit margin is -14.56%

Expenses

Total expenses

$2.06B
MASI annual total expenses is $2.06 billion

Operating expenses

$966.60M
MASI annual total operating expenses is $966.60 million

Cost of goods sold

$1.09B
MASI annual cost of goods sold is $1.09 billion

Selling, general & administrative expenses

$743.80M
MASI annual SGA is $743.80 million

Depreciation and amortization

$103.00M
MASI annual depreciation & amortization is $103.00 million

Interest expense

$43.60M
MASI annual interest expense is $43.60 million

Income tax

-$400.00K
MASI annual income tax is -$400.00 thousand

EBIT & EBITDA

EBIT

-$261.70M
MASI annual earnings before interest & taxes is -$261.70 million

EBITDA

-$158.70M
MASI annual EBITDA is -$158.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.63B
MASI annual total assets is $2.63 billion

Non current assets

$1.40B
MASI annual long term assets is $1.40 billion

Current assets

$1.23B
MASI annual total current assets is $1.23 billion

Cash and cash equivalents

$177.60M
MASI annual cash & cash equivalents is $177.60 million

Accounts receivable

$411.30M
MASI annual accounts receivable is $411.30 million

Inventory

$459.20M
MASI annual inventory is $459.20 million

Liabilities

Total liabilities

$1.57B
MASI annual total liabilities is $1.57 billion

Long term liabilities

$956.10M
MASI annual total long term liabilities is $956.10 million

Current liabilities

$617.70M
MASI annual total current liabilities is $617.70 million

Accounts payable

$252.80M
MASI annual accounts payable is $252.80 million

Debt

Total debt

$846.10M
MASI annual total debt is $846.10 million

Total debt 1-year change

-12.77%
MASI annual total debt is down -12.77% year-on-year

Long term debt

$787.40M
MASI annual long term debt is $787.40 million

Short term debt

$58.70M
MASI annual short term debt is $58.70 million

Equity & Capital

Shareholders equity

$1.05B
MASI annual stockholders equity is $1.05 billion

Book value

$1.05B
MASI annual book value is $1.05 billion

Retained earnings

$1.49B
MASI annual retained earnings is $1.49 billion

Working capital

$608.10M
MASI annual working capital is $608.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$196.40M
MASI annual cash flow from operations is $196.40 million

Cash from operations 1-year change

+108.71%
MASI annual cash flow from operations is up +108.71% year-on-year

Cash from investing

-$51.20M
MASI annual cash flow from investing activities is -$51.20 million

Cash from investing 1-year change

+36.95%
MASI annual cash flow from investing activities is up +36.95% year-on-year

Cash from financing

-$125.60M
MASI annual cash flow from financing activities is -$125.60 million

Cash from financing 1-year change

-119.96%
MASI annual cash flow from financing activities is down -119.96% year-on-year

CAPEX

CAPEX

$51.10M
MASI annual capital expenditures is $51.10 million

CAPEX 1-year change

-41.73%
MASI annual capital expenditures is down -41.73% year-on-year

Free Cash Flow

Free cash flow

$145.30M
MASI annual free cash flow is $145.30 million

Free cash flow 1-year change

+2170.31%
MASI annual free cash flow is up +2170.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

47.96%
MASI annual gross profit margin is 47.96%

Operating margin

1.80%
MASI annual operating profit margin is 1.80%

Net margin

-14.56%
MASI annual net profit margin is -14.56%

ROA & ROE

ROA

-10.76%
MASI annual return on assets is -10.76%

ROE

-25.23%
MASI annual return on equity is -25.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MASI price to earnings ratio value is unknown

PE ratio Sector rank

-
MASI price to earnings ratio is unknown

PB Ratio

PB ratio

7.88
MASI price to book ratio is 7.88

PB ratio Sector rank

90.29%
MASI price to book ratio is higher than 90.29% of companies in Healthcare sector

PS Ratio

PS ratio

3.96
MASI price to sales ratio is 3.96

PS ratio Sector rank

60.9%
MASI price to sales ratio is higher than 60.9% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.96B
MASI enterprise value is $8.96 billion

Enterprise value Sector rank

91.4%
MASI enterprise value is higher than 91.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-56.40
MASI EV/EBITDA is -56.40

EV/EBITDA Sector rank

2.09%
MASI EV/EBITDA is higher than 2.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.98
MASI annual current ratio is 1.98

Quick ratio

1.24
MASI annual quick ratio is 1.24

Leverage

Debt to equity

0.73
MASI annual debt to equity ratio is 0.73

Interest coverage ratio

-6.00
MASI annual interest coverage ratio is -6.00

Risk & Stability

Piotroski F-Score

4
MASI piotroski f-score is 4

Altman Z-Score

4.70
MASI altman z-score is 4.70

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Hold
Feb 26, 25 Wells Fargo
Overweight
Feb 26, 25 Piper Sandler
Overweight
Feb 26, 25 Needham
Hold
Jan 22, 25 Needham
Hold
Jan 16, 25 Needham
Hold
Dec 27, 24 Raymond James
Outperform
Dec 18, 24 Piper Sandler
Overweight
Dec 11, 24 Wells Fargo
Overweight
Nov 22, 24 Stifel
Buy

Institutional Ownership

Similar stocks

TECH logo
Bio-Techne (TECH)
EXAS logo
Exact Sciences (EXAS)
HSIC logo
Henry Schein (HSIC)
CHE logo
Chemed (CHE)
HALO logo
Halozyme Therapeutics (HALO)
VTRS logo
Viatris (VTRS)
ENSG logo
Ensign (ENSG)
QGEN logo
Qiagen NV (QGEN)
TEM logo
Tempus AI (TEM)
  • What is the ticker symbol for Masimo?
  • Does Masimo pay dividends?
  • What sector is Masimo in?
  • What industry is Masimo in?
  • What country is Masimo based in?
  • When did Masimo go public?
  • Is Masimo in the S&P 500?
  • Is Masimo in the NASDAQ 100?
  • Is Masimo in the Dow Jones?
  • When was Masimo's last earnings report?
  • When does Masimo report earnings?
  • Should I buy Masimo stock now?

What is the ticker symbol for Masimo?

The ticker symbol for Masimo is NASDAQ:MASI

Does Masimo pay dividends?

No, Masimo does not pay dividends

What sector is Masimo in?

Masimo is in the Healthcare sector

What industry is Masimo in?

Masimo is in the Medical Devices industry

What country is Masimo based in?

Masimo is headquartered in United States

When did Masimo go public?

Masimo's initial public offering (IPO) was on August 8, 2007

Is Masimo in the S&P 500?

No, Masimo is not included in the S&P 500 index

Is Masimo in the NASDAQ 100?

No, Masimo is not included in the NASDAQ 100 index

Is Masimo in the Dow Jones?

No, Masimo is not included in the Dow Jones index

When was Masimo's last earnings report?

Masimo's most recent earnings report was on Feb 25, 2025

When does Masimo report earnings?

The next expected earnings date for Masimo is May 7, 2025

Should I buy Masimo stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page